Interim versus standard methadone treatment: A benefit-cost analysis

Journal of Substance Abuse Treatment

Volumn 46, Issue 3, 2014, Pages 306-314

  Schwartz, Robert P ^a   Alexandre, Pierre K ^b   Kelly, Sharon M ^a   O'Grady, Kevin E ^c   Gryczynski, Jan ^a   Jaffe, Jerome H ^a,b,d  

^a FRIENDS RESEARCH INSTITUTE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Benefit cost; Interim methadone; Methadone treatment

Indexed keywords

METHADONE;

ADULT; ARTICLE; COST BENEFIT ANALYSIS; CRIMINAL JUSTICE; DRUG COST; DRUG DEPENDENCE TREATMENT; EMPLOYMENT; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HEROIN DEPENDENCE; HOSPITALIZATION; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MIDDLE AGED; PRIORITY JOURNAL;

BENEFIT-COST; INTERIM METHADONE; METHADONE TREATMENT;

ADULT; COST-BENEFIT ANALYSIS; COUNSELING; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; METHADONE; MIDDLE AGED; OPIOID-RELATED DISORDERS;

EID: 84892482998     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2013.10.003     Document Type: Article

References (44)

1. Agency for Healthcare Research, Quality [AHRQ] Medical Expenditure Panel Survey 2009, (Retrieved December 12, 2012, from http://meps.ahrq.gov/mepsweb/data_stats/tables_compendia_hh_interactive.jsp?_SERVICE= MEPSSocket0&_PROGRAM=MEPSPGM.TC.SAS&File=HCFY2009&Table=HCFY2009_PLEXP_E&VAR1=AGE&VAR2=SEX&VAR3=RACETH5C&VAR4=INSURCOV&VAR5=POVCAT09&VAR6=MSA&VAR7=REGION&VAR8=HEALTH&).
2. Alexandre P.K., Salome H.J., French M.T., Rivers J.E., McCoy C.B. Consequences and costs of closing a publicly funded methadone maintenance clinic. Social Science Quarterly 2002, 83:519-536.
3. Booth R.E., Corsi K.F., Mikulich-Gilbertson S.K. Factors associated with methadone maintenance treatment retention among street-recruited injection drug users. Drug and Alcohol Dependence 2004, 74:177-185. 10.1016/j.drugalcdep.2003.12.009.
4. Burke B.L., Arkowitz H., Menchola M. The efficacy of motivational interviewing: A meta-analysis of controlled clinical trials. Journal of Consulting and Clinical Psychology 2003, 71:843-861. 10.1037/0022-006X.71.5.843.
5. California Department of Alcohol and Drug Programs CALIFORNIA DRUG AND ALCOHOL TREATMENT ASSESSMENT (CALDATA), 1991-1993 [Computer file]. Conducted by the National Opinion Research Center at the University of Chicago and Lewin-VHI, Inc. ICPSR ed 2004, Inter-university Consortium for Political and Social Research, Ann Arbor, MI, (producer and distributor).
6. Clausen T., Anchersen K., Waal H. Mortality prior to, during and after opioid maintenance treatment (OMT): A national prospective cross-registry study. Drug and Alcohol Dependence 2008, 94:151-157. 10.1016/j.drugalcdep.2007.11.003.
7. Code of Federal Regulations 42 Part 8 Certification of opioid treatment programs 2001.
8. Cohen M.A., Miller T.R., Rossman S.B. The cost and consequences of violent behavior in the United States. Understanding and preventing violence: Consequences and control 1994, Vol. 4. National Academy Press, Nation Research Council, Washington, DC.
9. Daley M., Argeriou M., McCarty D., Callahan J.J., Shepard D.S., Williams C.N. The costs of crime and the benefits of substance abuse treatment for pregnant women. Journal of Substance Abuse Treatment 2000, 19:445-458.
10. Degenhardt L., Randall D., Hall W., Law M., Butler T., Burns L. Mortality among clients of a state-wide opioid pharmacotherapy program over 20years: Risk factors and lives saved. Drug and Alcohol Dependence 2009, 105:9-15. 10.1016/j.drugalcdep.2009.05.021.
11. Ettner S.L., Huang D., Evans E., Ash D.R., Hardy M., Jourabchi M., et al. Benefit-cost in the California treatment outcome project: Does substance abuse treatment "pay for itself"?. Health Service Research 2006, 41:192-213. 10.1111/j.1475-6773.2005.00466.x.
12. Federal Register Title 21 1993, (Codified at 58 CFR §495, pt 291).
13. Fiellin D.A., Pantalon M.V., Chawarski M.C., Moore B.A., Sullivan L.E., O'Connor P.G., et al. Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. New England Journal of Medicine 2006, 355:365-374. 10.1056/NEJMoa055255.
14. Flynn P.M., Kristiansen P.L., Porto J.V., Hubbard R.L. Costs and benefits of treatment for cocaine addiction in DATOS. Drug and Alcohol Dependence 1999, 57:167-174. 10.1016/S0376-8716(99)00083-6.
15. Flynn P.M., Porto J.V., Rounds-Bryant J.L., Kristiansen P.L. Costs and benefits of methadone treatment in DATOS-Part 1. Discharged versus continuing patients. Journal of Maintenance in the Addictions 2002, 2:129-149.
16. French M.T., Dunlap L.J., Zarkin G.A., McGeary K.A., McLellan A.T. A structured instrument for estimating the economic cost of drug abuse treatment. The Drug Abuse Treatment Cost Analysis Program (DATCAP). Journal of Substance Abuse Treatment 1997, 14:445-455.
17. French M.T., Martin R.F. The costs of drug abuse consequences: A summary of research findings. Journal of Substance Abuse Treatment 1996, 13:453-466.
18. French M.T., Salome H.J., Carney M. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington. Social Sciences & Medicine 2002, 55:2267-2282.
19. French M.T., Salome H.J., Krupski A., McKay J.R., Donovan D.M., McLellan A.T., et al. Benefit-cost analysis of residential and outpatient addiction treatment in the State of Washington. Evaluation Review 2000, 24:609-634. 10.1177/0193841X0002400603.
20. Gibson A., Degenhardt L., Mattick R.P., Ali R., White J., O'Brien S. Exposure to opioid maintenance treatment reduces long-term mortality. Addiction 2008, 103:462-468. 10.1111/j.1360-0443.2007.02090.x.
21. Godfrey C., Stewart D., Gossop M. Economic analysis of costs and consequences of the treatment of drug misuse: 2-Year outcome data from the National Treatment Outcome Research Study (NTORS). Addiction 2004, 99:697-707. 10.1111/j.1360-0443.2004.00752.x.
22. Gossop M., Marsden J., Stewart D., Lehmann P., Strang J. Methadone treatment practices and outcome for opiate addicts treated in drug clinics and in general practice: Results from the National Treatment Outcome Research Study. The British Journal of General Practice 1999, 49:31-34.
23. Gruber V.A., Delucchi K.L., Kielstein A., Batki S.L. A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification. Drug and Alcohol Dependence 2008, 94:199-206. 10.1016/j.drugalcdep.2007.11.021.
24. Harwood H.J., Hubbard R.L., Collins J.J., Rachal J.V. The costs of crime and the benefits of drug abuse treatment: A cost-benefit analysis using TOPS data. NIDA Research Monograph 1988, 86:209-235.
25. Health Services Cost Review Commission The Maryland Health Services Cost Review Commission 2013, (From http://www.hscrc.state.md.us/).
26. Keen J., Rowse G., Mathers N., Campbell M., Seivewright N. Can methadone maintenance for heroin-dependent patients retained in general practice reduce criminal conviction rates and time spent in prison?. The British Journal of General Practice 2000, 50:48-49.
27. Kelly S.M., Schwartz R.P., O'Grady K.E., Gandhi D., Jaffe J.H. Impact of methadone with versus without drug abuse counseling on HIV Risk: 4- and 12-month findings from a clinical trial. Journal of Addiction Medicine 2012, 6:145-152. 10.1097/ADM.0b013e31823ae556.
28. Knapp W.P., Soares B.G., Farrel M., Lima M.S. Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders. Cochrane Database of Systematic Reviews, 18, CD003023 2007, 10.1002/14651858.CD003023.pub2.
29. Koenig L., Denmead G., Nguyen R., Harrison M., Harwood H.J. The costs and benefits of substance abuse treatment: Findings from the National Treatment Improvement Evaluation Study (NTIES) (NEDS Contracto No. 270-97-7016) 1999, (From http://www.lewin.com/~/media/Lewin/Site_Sections/Publications/1563.pdf).
30. Lewis D., Bellis M. General practice or drug clinic for methadone maintenance? A controlled comparison of treatment outcomes. The International Journal of Drug Policy 2001, 12:81-89.
31. Maryland Department of Legislative Services Fiscal and Policy Note for the Child Protection from Predators Act of 2008. HB 73 Judiciary, Department of Legislative Services, Maryland General Assembly, 2008 Session 2008, (Retrieved November 17, 2011, from http://mlis.state.md.us/2008rs/fnotes/bil_0003/hb0073.pdf).
32. McCambridge J., Strang J. The efficacy of single-session motivational interviewing in reducing drug consumption and perceptions of drug-related risk and harm among young people: Results from a multi-site cluster randomized trial. Addiction 2004, 99:39-52. 10.1111/j.1360-0443.2004.00564.x.
33. McCollister K.E., French M.T. The relative contribution of outcome domains in the total economic benefit of addiction interventions: A review of first findings. Addiction 2003, 98:1647-1659. 10.1111/j.1360-0443.2003.00541.x.
34. Salomé H.J., French M.T., Scott C.K., Foss M., Dennis M. Investigating variation in the costs and benefits of addiction treatment: Econometric analysis of the Chicago Target Cities Project. Evaluation and Program Planning 2003, 26:325-338. 10.1016/S0149-7189(03)00036-3.
35. Schwartz R.P., Highfield D.A., Jaffe J.H., Brady J.V., Butler C.B., Rouse C.O., et al. A randomized controlled trial of interim methadone maintenance. Archives of General Psychiatry 2006, 63:102-109. 10.1001/archpsyc.63.1.102.
36. Schwartz R.P., Jaffe J.H., Highfield D.A., Callaman J.M., O'Grady K.E. A randomized controlled trial of interim methadone maintenance: 10-Month follow-up. Drug and Alcohol Dependence 2007, 86:30-36. 10.1016/j.drugalcdep.2006.04.017.
37. Schwartz R.P., Kelly S.M., O'Grady K.E., Gandhi D., Jaffe J.H. Interim methadone treatment compared to standard methadone treatment: 4-Month findings. Journal of Substance Abuse Treatment 2011, 41:21-29. 10.1016/j.jsat.2011.01.008.
38. Schwartz R.P., Kelly S.M., O'Grady K.E., Gandhi D., Jaffe J.H. Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-Month findings. Addiction 2012, 107:943-952. 10.1111/j.1360-0443.2011.03700.x.
39. Senay E.C., Jaffe J.H., diMenza S., Renault P.F. A 48-week study of methadone, methadyl acetate and minimal services. Opiate dependence: Origins and treatment 1973, 185-201. Halstead Press, New York, NY. S. Fisher, A. Freeman (Eds.).
40. Teesson M., Mills K., Ross J., Darke S., Williamson A., Havard A. The impact of treatment on 3years' outcome for heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS). Addiction 2008, 103:80-88. 10.1111/j.1360-0443.2007.02029.x.
41. Weiss R.D., Potter J.S., Fiellin D.A., Byrne M., Connery H.S., Dickinson W., et al. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial. Archives of General Psychiatry 2011, 68:1238-1246. 10.1001/archgenpsychiatry.2011.121.
42. Yancovitz S.R., Des Jarlais D.C., Peyser N.P., Drew E., Friedmann P., Trigg H.L., et al. A randomized trial of an interim methadone maintenance clinic. American Journal of Public Health 1991, 81:1185-1191.
43. Zanis D.A., Woody G.E. One-year mortality rates following methadone treatment discharge. Drug and Alcohol Dependence 1998, 52:257-260. 10.1016/S0376-8716(98)00097-0.
44. Zarkin G.A., Dunlap L.J., Hicks K.A., Mamo D. Benefits and costs of methadone treatment: Results from a lifetime simulation model. Health Economics 2005, 14:1133-1150. 10.1002/hec.999.